Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
Background. To evaluate the clinical efficacy of In-111 DTPA octreotide SPECT/CT and Ga-68 DOTATOC PET/CT for detection of primary tumors in patients with either neuroendocrine tumor of unknown primary (NETUP) or clinically suspected primary NET (SNET).
Main Authors: | Schreiter Nils Friedemann, Bartels Ann-Mirja, Froeling Vera, Steffen Ingo, Pape Ulrich-Frank, Beck Alexander, Hamm Bernd, Brenner Winfried, Röttgen Rainer |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2014-12-01
|
Series: | Radiology and Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/raon-2014-0018 |
Similar Items
-
Combination 111In and 177Lu –Dotatoc and Vaccinia Virus Oncolytic Therapy for SSTR2-positive Tumors
by: Akinlolu, Olayinka
Published: (2009) -
Combination 111In and 177Lu –Dotatoc and Vaccinia Virus Oncolytic Therapy for SSTR2-positive Tumors
by: Akinlolu, Olayinka
Published: (2009) -
Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
by: Manuel Weber, et al.
Published: (2020-04-01) -
Radiosynthesis and Animal Studies of 111In-DTPA-bis-alendronate Complex
by: Ashraf Fakhari, et al.
Published: (2015-09-01) -
Solitary late metastasis of primary renal cell carcinoid tumor to the extraocular muscles imaged with indium-111 octreotide
by: Philip Jude Dempsey, et al.
Published: (2021-01-01)